Concepedia

Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial

Herjan J.T Coelingh Bennink, Bart C.J.M. Fauser, Henk J. Out

Fertility and Sterility · 1998 · 100 citations · 14 references

DOI

Concepts

References

14

Clinical gynecologic endocrinology and infertility

Elizabeth A. Kennard · Trends in Endocrinology and Metabolism · 1995 · 250 citations

, , +11

Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.

Davinia White, D. W. POLSON, D. Kiddy et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 237 citations · Full text

, , +14

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization

Henk J. Out, Bernadette Mannaerts, Stefan Driessen et al. · Human Reproduction · 1995 · 214 citations

Good Clinical Practice for Trials on Medicinal Products in the European Community: CPMP Working Party on Efficacy of Medicinal Products

Pharmacology & Toxicology · 1990 · 124 citations

, , +9

A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome

Roy Homburg, Tally Levy, Zion Ben‐Rafael · Fertility and Sterility · 1995 · 116 citations

, , +11